Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Konakion MM Paediatric 2mg/0.2ml ampoules to face supply disruption

The Department of Health and Social Care has issued a medicine supply notification for Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules of Cheplapharm.

UK licensed Konakion MM Paediatric will remain out of stock in November.


Supplies of the drug in tri-lingual packaging including English, considered unlicensed in the UK, are available as alternative medicine.

When prescribing a product that is not licensed in the UK, the prescribers must indicate on the FP10 prescription that an unlicensed product is required. This can be done by annotating the prescription with the following wording: special order.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems.

If a prescriber wishes to prescribe an unlicensed import, a paper prescription should be issued as ‘Phytomenadione 2mg/0.2ml ampoules (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

Ferrous Fumarate 322mg/Folic Acid 350mcg

The department has further extended a medicine supply notification for Ferrous Fumarate 322mg/Folic Acid 350mcg (Pregaday) tablets of Recipharm.

Pregaday tablets will be out of stock until late November.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less